This scholarly profile was discovered from public research metadata and has not yet been claimed. Is this your research profile?
Henrik Zetterberg
UnverifiedResearcher · US
Publications
10
Citations
19901
max across sources
Profile views
5
bot-filtered
Verification
L0
Overview
AI-generatedHenrik Zetterberg (RTX-00000121) based in US is a researcher on ResearchTrics. Lists research interests: alzheimer's disease research and treatments, amyotrophic lateral sclerosis research, dementia and cognitive impairment research, neuroinflammation and neurodegeneration mechanisms, s100 proteins and annexins. Has 10 publications recorded, including "Hallmarks of neurodegenerative diseases" (2023), "Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders" (2020), "Neurofilaments as biomarkers in neurological disorders" (2018).
An AI overview generated from this profile’s verified records — an interpretation, not a verified statement.
Research interests
- alzheimer's disease research and treatments
- amyotrophic lateral sclerosis research
- dementia and cognitive impairment research
- neuroinflammation and neurodegeneration mechanisms
- s100 proteins and annexins
Publications (20)
- Hallmarks of neurodegenerative diseases1775 cites
Cell · 2023 · DOI
- Hallmarks of neurodegenerative diseases1775 cites
Cell · 2023 · DOI
- Neurofilaments as biomarkers in neurological disorders2036 cites
Nature Reviews Neurology · 2018 · DOI
- Neurofilaments as biomarkers in neurological disorders2036 cites
Nature Reviews Neurology · 2018 · DOI
- Gut microbiome alterations in Alzheimer’s disease2170 cites
Scientific Reports · 2017 · DOI
- Gut microbiome alterations in Alzheimer’s disease2170 cites
Scientific Reports · 2017 · DOI
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis2132 cites
The Lancet Neurology · 2016 · DOI
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis2132 cites
The Lancet Neurology · 2016 · DOI
- Defeating Alzheimer's disease and other dementias: a priority for European science and society1712 cites
The Lancet Neurology · 2016 · DOI
- Defeating Alzheimer's disease and other dementias: a priority for European science and society1712 cites
The Lancet Neurology · 2016 · DOI
- Clearance systems in the brain—implications for Alzheimer disease1722 cites
Nature Reviews Neurology · 2015 · DOI
- Clearance systems in the brain—implications for Alzheimer disease1722 cites
Nature Reviews Neurology · 2015 · DOI
- Cerebrospinal fluid and plasma biomarkers in Alzheimer disease1896 cites
Nature Reviews Neurology · 2010 · DOI
- Cerebrospinal fluid and plasma biomarkers in Alzheimer disease1896 cites
Nature Reviews Neurology · 2010 · DOI
- Alzheimer's disease3113 cites
The Lancet · 2006 · DOI
- Alzheimer's disease3113 cites
The Lancet · 2006 · DOI
- Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study1708 cites
The Lancet Neurology · 2006 · DOI
- Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study1708 cites
The Lancet Neurology · 2006 · DOI
